vs

Side-by-side financial comparison of SuperCom Ltd (SPCB) and Wave Life Sciences Ltd. (WVE). Click either name above to swap in a different company.

SuperCom Ltd is the larger business by last-quarter revenue ($14.2M vs $8.7M, roughly 1.6× Wave Life Sciences Ltd.). SuperCom Ltd runs the higher net margin — 37.5% vs -580.2%, a 617.7% gap on every dollar of revenue. On growth, SuperCom Ltd posted the faster year-over-year revenue change (-1.5% vs -55.8%). SuperCom Ltd produced more free cash flow last quarter ($-3.6M vs $-46.3M).

Super.com is a technology company headquartered in San Francisco and co-founded by Hussein Fazal and Henry Shi. The company provides financial services, including reward programs and travel bookings.

BIT Life Sciences is a for profit meetings, incentives, conferencing, exhibitions (MICE) company based in Dalian, China, that specializes in arranging multiple scientific congresses that have been described as "predatory". The company is part of a wave of organizations that have appeared in China in the past several years noted for arranging congresses with little academic merit and with the primary aim of generating revenue rather than scientific knowledge sharing. Papers submitted are usual...

SPCB vs WVE — Head-to-Head

Bigger by revenue
SPCB
SPCB
1.6× larger
SPCB
$14.2M
$8.7M
WVE
Growing faster (revenue YoY)
SPCB
SPCB
+54.4% gap
SPCB
-1.5%
-55.8%
WVE
Higher net margin
SPCB
SPCB
617.7% more per $
SPCB
37.5%
-580.2%
WVE
More free cash flow
SPCB
SPCB
$42.7M more FCF
SPCB
$-3.6M
$-46.3M
WVE

Income Statement — Q2 FY2025 vs Q2 FY2025

Metric
SPCB
SPCB
WVE
WVE
Revenue
$14.2M
$8.7M
Net Profit
$5.3M
$-50.5M
Gross Margin
61.2%
Operating Margin
16.3%
-606.5%
Net Margin
37.5%
-580.2%
Revenue YoY
-1.5%
-55.8%
Net Profit YoY
79.5%
-53.3%
EPS (diluted)
$1.32
$-0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SPCB
SPCB
WVE
WVE
Q2 25
$14.2M
$8.7M
Q1 25
$9.2M
Q2 24
$14.4M
$19.7M
Q1 24
$12.5M
Q4 23
$29.1M
Q3 23
$49.2M
Q2 23
$14.1M
$22.1M
Q1 23
$12.9M
Net Profit
SPCB
SPCB
WVE
WVE
Q2 25
$5.3M
$-50.5M
Q1 25
$-46.9M
Q2 24
$3.0M
$-32.9M
Q1 24
$-31.6M
Q4 23
$-16.3M
Q3 23
$7.3M
Q2 23
$-2.6M
$-21.1M
Q1 23
$-27.4M
Gross Margin
SPCB
SPCB
WVE
WVE
Q2 25
61.2%
Q1 25
Q2 24
52.3%
Q1 24
Q4 23
Q3 23
Q2 23
27.2%
Q1 23
Operating Margin
SPCB
SPCB
WVE
WVE
Q2 25
16.3%
-606.5%
Q1 25
-542.8%
Q2 24
7.7%
-177.7%
Q1 24
-274.8%
Q4 23
-64.3%
Q3 23
9.0%
Q2 23
-12.2%
-106.2%
Q1 23
-234.2%
Net Margin
SPCB
SPCB
WVE
WVE
Q2 25
37.5%
-580.2%
Q1 25
-510.9%
Q2 24
20.6%
-167.2%
Q1 24
-251.7%
Q4 23
-55.9%
Q3 23
14.7%
Q2 23
-18.3%
-95.5%
Q1 23
-212.0%
EPS (diluted)
SPCB
SPCB
WVE
WVE
Q2 25
$1.32
$-0.31
Q1 25
$-0.29
Q2 24
$1.19
$-0.25
Q1 24
$-0.24
Q4 23
$-0.14
Q3 23
$0.07
Q2 23
$-10.66
$-0.20
Q1 23
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SPCB
SPCB
WVE
WVE
Cash + ST InvestmentsLiquidity on hand
$15.0M
$208.5M
Total DebtLower is stronger
$23.6M
Stockholders' EquityBook value
$37.3M
$139.3M
Total Assets
$65.5M
$252.4M
Debt / EquityLower = less leverage
0.63×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SPCB
SPCB
WVE
WVE
Q2 25
$15.0M
$208.5M
Q1 25
$243.1M
Q2 24
$5.7M
$154.0M
Q1 24
$180.9M
Q4 23
$200.4M
Q3 23
$139.9M
Q2 23
$1.1M
$173.0M
Q1 23
$207.6M
Total Debt
SPCB
SPCB
WVE
WVE
Q2 25
$23.6M
Q1 25
Q2 24
$29.2M
Q1 24
Q4 23
Q3 23
Q2 23
$32.9M
Q1 23
Stockholders' Equity
SPCB
SPCB
WVE
WVE
Q2 25
$37.3M
$139.3M
Q1 25
$171.8M
Q2 24
$13.8M
$-3.5M
Q1 24
$25.4M
Q4 23
$39.6M
Q3 23
$-40.5M
Q2 23
$3.5M
$-51.7M
Q1 23
$-34.7M
Total Assets
SPCB
SPCB
WVE
WVE
Q2 25
$65.5M
$252.4M
Q1 25
$288.3M
Q2 24
$49.6M
$208.8M
Q1 24
$235.3M
Q4 23
$274.9M
Q3 23
$199.9M
Q2 23
$40.8M
$230.0M
Q1 23
$267.3M
Debt / Equity
SPCB
SPCB
WVE
WVE
Q2 25
0.63×
Q1 25
Q2 24
2.11×
Q1 24
Q4 23
Q3 23
Q2 23
9.49×
Q1 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SPCB
SPCB
WVE
WVE
Operating Cash FlowLast quarter
$-2.2M
$-46.0M
Free Cash FlowOCF − Capex
$-3.6M
$-46.3M
FCF MarginFCF / Revenue
-25.3%
-532.5%
Capex IntensityCapex / Revenue
10.0%
3.5%
Cash ConversionOCF / Net Profit
-0.41×
TTM Free Cash FlowTrailing 4 quarters
$-14.0M
$-170.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SPCB
SPCB
WVE
WVE
Q2 25
$-2.2M
$-46.0M
Q1 25
$-63.0M
Q2 24
$-950.0K
$-27.5M
Q1 24
$-33.4M
Q4 23
$-33.2M
Q3 23
$-34.5M
Q2 23
$-3.4M
$-37.3M
Q1 23
$85.5M
Free Cash Flow
SPCB
SPCB
WVE
WVE
Q2 25
$-3.6M
$-46.3M
Q1 25
$-63.2M
Q2 24
$-1.6M
$-27.5M
Q1 24
$-33.8M
Q4 23
$-33.6M
Q3 23
$-34.7M
Q2 23
$-4.5M
$-37.3M
Q1 23
$85.0M
FCF Margin
SPCB
SPCB
WVE
WVE
Q2 25
-25.3%
-532.5%
Q1 25
-688.9%
Q2 24
-10.8%
-139.8%
Q1 24
-270.0%
Q4 23
-115.6%
Q3 23
-70.4%
Q2 23
-31.5%
-168.9%
Q1 23
657.7%
Capex Intensity
SPCB
SPCB
WVE
WVE
Q2 25
10.0%
3.5%
Q1 25
1.8%
Q2 24
4.2%
0.3%
Q1 24
3.3%
Q4 23
1.2%
Q3 23
0.4%
Q2 23
7.4%
0.3%
Q1 23
3.8%
Cash Conversion
SPCB
SPCB
WVE
WVE
Q2 25
-0.41×
Q1 25
Q2 24
-0.32×
Q1 24
Q4 23
Q3 23
-4.75×
Q2 23
Q1 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons